Non High-Density Lipoprotein Cholesterol in Type2 Diabetic Patients

Elleuch, Mouna and Charfi, Hana and Mekki, Sahar and Salah, Dhoha Ben and Sefi, Wajdi and Arbi, Kaouthar El and Boujelbene, Khouloud and Charfi, Nedia and Mnif, Fatma and Mnif, Mouna and Kacem, Faten Hadj and Abid, Mohamed Non High-Density Lipoprotein Cholesterol in Type2 Diabetic Patients. Asian Journal of Research and Reports in Endocrinology, 4 (2). pp. 10-15.

[thumbnail of 35-Article Text-60-1-10-20220831.pdf] Text
35-Article Text-60-1-10-20220831.pdf - Published Version

Download (596kB)

Abstract

Aims: To study the relationship between non high-density lipoprotein cholesterol (non-HDL-C) and metabolic disorders in type2 diabetic patients and to prove the incrimination of non-HDL-C in the genesis of chronic complications of diabetes.

Study Design: Retrospective study.

Place and Duration of Study: Endocrinology-Diabetology Department of Hedi Chaker University Hospital of Sfax for a period of two months, January and February 2020.

Methodology: We included80 type2 diabetic patients (34 men and 46 women; age range: 22-72 years) with metabolic syndrome. Each patient had undergone a complete clinical examination and biochemistry test, then, the non-HDL-C was calculated.

Results: Out of 80 patients, 57 suffered from diabetic complications like micro vascular and macro vascular complications. Unbalanced diabetes was identified in 73.75% of the patients. All the patients had a high level of non-HDL-C.

No significant positive correlation was confirmed between non-HDL-C with body mass index, glycemic parameters, triglycerides, or total cholesterol.

Correlation between the level of non-HDL-C and coronary artery disease, myocardial infarction (MI), and stroke was identified with p values of 0.016, 0.05, and 0.04, respectively.

Patients with microvascular complications had higher levels of non-HDL-C but a positive correlation was only relevant with diabetic nephropathy (p=0.026).

Conclusion: Our study confirmed that non-HDL-C is a simple and reliable indicator of the overall risk of cardiovascular disease, thus, it may be equivalent, if not superior, to low-density lipoprotein cholesterol (LDL-C). Therefore, it should be our primary lipid treatment target for diabetic patients.

Item Type: Article
Subjects: West Bengal Archive > Medical Science
Depositing User: Unnamed user with email support@westbengalarchive.com
Date Deposited: 24 Mar 2023 09:24
Last Modified: 26 Jul 2024 07:04
URI: http://article.stmacademicwriting.com/id/eprint/212

Actions (login required)

View Item
View Item